Tolga Tanguler - Aug 3, 2022 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Signature
By: /s/ Mary Beth DeLena, Attorney-in-Fact For: Tolga Tanguler
Stock symbol
ALNY
Transactions as of
Aug 3, 2022
Transactions value $
-$1,112,787
Form type
4
Date filed
8/5/2022, 04:15 PM
Previous filing
Jul 7, 2022
Next filing
Feb 3, 2023

Transactions Table

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 24, 2021, the reporting person was granted a one-time strategic performance-based stock unit (PSU) award. The People, Culture and Compensation Committee of the Board determined that the performance criterion was met and the PSU award vested as of August 3, 2022.
F2 These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 2, 2022.
F3 Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting event.
F4 Sale prices ranged from $214.86 to $215.13.
F5 Sale prices ranged from $216.01 to $217.01.
F6 Sale prices ranged from $217.10 to $218.10
F7 Sale prices ranged from $218.14 to $219.09.